Blocking cancer-spreading proteins
Hebrew University of Jerusalem scientists have designed molecules that stop cancer-promoting proteins from accelerating tumor growth. These molecules (called oligonucleotides) bind with the proteins, preventing them from binding with RNA molecules in cancer cells. The tumors then die.
Certification for cancer radiation treatment
I reported previously on Israel’s Alpha Tau and its Alpha DaRT radiation therapy for cancer patients. It has just obtained UK certification following an audit by the British Standards Institution – the UK's independent compliance body.
The best antidepressant
Israel’s Taliaz is partnering with Psychiatry UK to deliver artificial intelligence-driven genetic testing to depression sufferers. Their Predictix service aims to reduce patient suffering by helping psychiatrists better identify the right antidepressant medication earlier.
A factory for gene therapies
Israel’s Stem Cell Medicine (SCM) uses gene therapy to develop new treatments for neurological indications and rare diseases. Israel’s Ministry of the Economy is funding SCM’s new gene therapy facility in Jerusalem. SCM’s first product is to treat neuropathic pain.
Bacteria can “sense” pregnancy
Scientists at Israel’s Bar-Ilan University have proved that the bacteria Bifidobacterium in a woman’s intestine can “sense” her pregnancy. It then grows quickly, to assist babies in breaking down the sugar in mother's milk. The bacteria’s growth is triggered by the hormone progesterone.
First live op using holographic imaging
Surgeons at Toronto General Hospital performed the first live medical procedure using real-time holographic imaging developed by Israel’s RealView Imaging . The 3D images allowed the surgeons to see inside the heart prior to a mitral valve replacement procedure.
Fast test to identify the right antibiotic
I’ve reported previously on the many Israeli innovations that are trying to prevent antibiotics from becoming ineffective. Now Israeli startup Nanosynex offers a 4-hour test to determine which antibiotic will be effective and what dose to use to prevent it developing resistance.
First ever vein transplant from living donor
Avi Yavetz from Modi’in suffers from peripheral vascular disease (PVD) and a leg amputation was imminent. However, his son, 27-year-old Snir donated a long vein, which was implanted into his father in a first of its kind operation. Two weeks later and both are doing fine.
Brain monitoring in real time
I reported previously on the computer interface device from Israel’s Neurosteer used to monitor brain activity. The three-strip wearable device is now in clinical trials in Israel, Europe and the United States and proving far simpler and more useful than EEG and fMRI alternatives.
US approval for surgical mesh
I reported previously on the innovative FasTouch fixation system from Israel’s Via Surgical for hernia repairs. The company has just announced that it has received US FDA approval for the system.